Loading…
Amphastar Pharmaceuticals, Inc. is projected to rise to $22.68 by 2027, a +14% move from its current price of $19.94. AMPH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $19.50 | $19.95 | $20.41 | +0.05% |
| Aug 3 | $19.33 | $19.96 | $20.61 | +0.11% |
| Aug 4 | $19.20 | $19.97 | $20.77 | +0.16% |
| Aug 5 | $19.10 | $19.98 | $20.91 | +0.21% |
| Aug 6 | $19.00 | $19.99 | $21.03 | +0.26% |
| Aug 7 | $18.92 | $20.00 | $21.15 | +0.32% |
| Aug 8 | $18.85 | $20.01 | $21.25 | +0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $18.85 | $20.01 | $21.25 | +0.37% |
| Week 2 | $18.45 | $20.09 | $21.87 | +0.74% |
| Week 3 | $18.17 | $20.16 | $22.37 | +1.11% |
| Week 4 | $17.95 | $20.24 | $22.82 | +1.49% |
| Week 5 | $17.76 | $20.31 | $23.23 | +1.86% |
| Week 6 | $17.60 | $20.39 | $23.62 | +2.24% |
| Week 7 | $17.46 | $20.46 | $23.99 | +2.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Amphastar Pharmaceuticals, Inc. is a bio-pharmaceutical company. It develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
Founded in 1996 and headquartered in Rancho Cucamonga, California, the company operates within the Healthcare sector. Its diverse portfolio includes emergency and diagnostic products as well as API offerings, reflecting a broad engagement in pharmaceutical development and manufacturing for multiple delivery modalities.
Amphastar Pharmaceuticals, Inc. (AMPH) is a Healthcare stock with a current price of $20.58 and a market cap of $907.43M. It ranks 2597 by market capitalization in the sector.
The near-term technical picture shows the stock trading within a 30-day range of $17.61 to $24.05, signaling some volatility but a constructive setup given recent price action. The forecasted path from 2026 onward suggests a clear upside trajectory, with the 2026 average priced at $20.58 and continuing to rise in subsequent years.
Looking further out, the multi-year forecast paints substantial upside: 2030 average price is $36.37, 2040 average price is $84.56, and 2050 average price is $176.48. Corresponding ROIs are 76.7% for 2030, 310.9% for 2040, and 757.5% for 2050, indicating meaningful long-term appreciation potential while acknowledging uncertainty and the inherent variability of price forecasts.
A major floor 16.9% below — a decisive break under it would weaken the trend.
The nearest floor, 8.1% below — buyers have tended to step in here.
The nearest ceiling, 9.2% above — a clean break opens room to run.
A major ceiling 20.5% above — clearing it would confirm fresh momentum.
Key AMPH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AMPH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $20.05 | Sell | $19.99 | Sell |
| MA 10 | $19.63 | Buy | $19.79 | Buy |
| MA 20 | $19.49 | Buy | $19.68 | Buy |
| MA 50 | $19.49 | Buy | $19.79 | Buy |
| MA 100 | $19.87 | Buy | $20.61 | Sell |
| MA 200 | $22.95 | Sell | $22.53 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.50 | Neutral |
| Stoch RSI (14) | 61.47 | Neutral |
| CCI (20) | 64.25 | Neutral |
| Williams %R (14) | -34.41 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | 2.78 | Buy |
| Bollinger %B (20,2) | 0.71 | Neutral |
| Stochastic %K (14) | 65.59 | Neutral |
| TRIX (15) | -0.02 | Sell |
| Awesome (5,34) | 0.34 | Buy |
| Ultimate (7,14,28) | 58.59 | Neutral |
| Momentum (10) | 0.19 | Buy |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 20.62 | Sell |
| ADX (14) | 9.11 | Neutral |
| ATR (14) | 0.43 | Info |
The 30-day technical picture remains bullish, with RSI14 at 60 and momentum supported by a price above the 50-day average. The stock sits above the SMA50 of $19.39 but below the SMA200 of $22.99, suggesting near-term sideways-to-firm bias as it encroaches longer-term resistance.
Key support sits at $18.33 and resistance at $21.78, framing a near-term trading zone. The 30-day range spans from $17.61 to $24.05, highlighting contained volatility but with upside potential if resistance is breached.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.87 | $19.94 | $25.15 | 0% | Neutral | |
| $18.36 | $22.68 | $29.43 | +14% | Neutral | |
| $18.73 | $23.67 | $31.71 | +19% | Neutral | |
| $22.01 | $28.35 | $38.95 | +42% | Bullish | |
| $26.41 | $34.58 | $48.52 | +73% | Bullish | |
| $28.59 | $38.01 | $54.33 | +91% | Bullish | |
| $31.25 | $42.13 | $61.21 | +111% | Bullish | |
| $32.88 | $44.91 | $66.25 | +125% | Bullish | |
| $33.99 | $47.01 | $70.30 | +136% | Bullish | |
| $35.29 | $49.37 | $74.80 | +148% | Bullish | |
| $53.99 | $79.65 | $127.38 | +299% | Bullish | |
| $101.88 | $164.33 | $284.55 | +724% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $16.87 | $19.94 | $23.73 | +0.00% |
| September 2026 | $17.36 | $20.44 | $24.68 | +2.52% |
| October 2026 | $17.67 | $20.92 | $25.48 | +2.35% |
| November 2026 | $17.31 | $20.59 | $25.26 | -1.60% |
| December 2026 | $17.05 | $20.37 | $25.15 | -1.07% |
Click any year to see its month-by-month AMPH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, AMPH is projected to trade between $16.87 and $25.15, averaging $19.94 — a potential gain of 0% from today's $19.94. A consolidation phase looks the most probable path here.
Amphastar Pharmaceuticals, Inc.'s 2027 outlook centres on $22.68, within a $18.36 to $29.43 range. That is up +14% on the projected 2026 average. That marks a +14% change versus current levels. Price action looks broadly range-bound.
By 2028, AMPH could reach as high as $31.71, with a base case around $23.67 and support toward $18.73 — roughly +19% from $19.94. A consolidation phase looks the most probable path here.
Expect AMPH to range from $22.01 to $38.95 through 2029. The $28.35 average target implies a +42% move from current prices. That is up +20% on the projected 2028 average. Momentum favours further upside here.
The AMPH price prediction for 2030 points to an average of $34.58 (low $26.41, high $48.52) — a potential gain of +73% on today's $19.94. Buyers look set to stay in control over this stretch.
In 2031, AMPH is projected to trade between $28.59 and $54.33, averaging $38.01 — a potential gain of +91% from today's $19.94. That is up +10% on the projected 2030 average. Momentum favours further upside here.
Amphastar Pharmaceuticals, Inc.'s 2032 outlook centres on $42.13, within a $31.25 to $61.21 range. That is up +11% on the projected 2031 average. That marks a +111% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, AMPH could reach as high as $66.25, with a base case around $44.91 and support toward $32.88 — roughly +125% from $19.94. Momentum favours further upside here.
Expect AMPH to range from $33.99 to $70.30 through 2034. The $47.01 average target implies a +136% move from current prices. That is up +5% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The AMPH price prediction for 2035 points to an average of $49.37 (low $35.29, high $74.80) — a potential gain of +148% on today's $19.94. Momentum favours further upside here.
In 2040, AMPH is projected to trade between $53.99 and $127.38, averaging $79.65 — a potential gain of +299% from today's $19.94. That is up +61% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Amphastar Pharmaceuticals, Inc.'s 2050 outlook centres on $164.33, within a $101.88 to $284.55 range. That is up +106% on the projected 2040 average. That marks a +724% change versus current levels. Momentum favours further upside here.
Investing $1,000 in AMPH today (≈ 50.150451 AMPH) could be worth
$8,241.34
+$7,241.34 (+724%) by 2050 · US Dollar
Based on the average projected AMPH price of $164.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AMPHwould be worth at today's price.
$1,000 invested in AMPH on Jul 31, 2025 (≈ 47.732695 AMPH) would be worth
$951.79
-$48.21 (-4.8%) today · 0.95× · US Dollar
Based on a AMPH entry price of $20.95 vs. today's $19.94.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $18.72 | $1,065.17 | +6.5% |
| 1 month ago | $20.1 | $992.04 | -0.8% |
| 3 months ago | $21.88 | $911.33 | -8.9% |
| 6 months ago | $27.92 | $714.18 | -28.6% |
| 1 year ago | $20.95 | $951.79 | -4.8% |
| All time (5.0y) ago | $21.24 | $938.79 | -6.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AMPH forecast.
Our base-case forecast reaches $40.00 around 2032.
Implied market cap at $40.00: $1.76B
The multi-year forecast outlines an upside path across the horizon years. By 2030 the average price is projected at $36.37, up from 2026’s $20.58, with a 76.7% ROI. By 2040 the average reaches $84.56 and the ROI climbs to 310.9%, with the price path continuing higher to an average of $176.48 in 2050 and a ROI of 757.5%.
This trajectory points to sustained upside through mid- and late decade horizons, with later years showing pronounced appreciation potential.
The sequence of years shows incremental gains in the earlier steps (e.g., 2027 avg $23.51; 2028 avg $24.49; 2029 avg $29.64) leading to sharper gains in the 2030s and beyond, culminating in large-scale upside by 2050. These figures reflect estimates and are not guarantees, and they come with the typical investment risks and market uncertainties associated with equity markets and healthcare stocks.
Tap a question to reveal the answer.
2030 avg $36.37; min $27.61; max $51.40; ROI 76.7%; sentiment BULLISH.
The forecast shows rising averages from 2026 avg $20.58 to 2050 avg $176.48 with bullish sentiment in later years; ROIs include 76.7% by 2030, 310.9% by 2040, and 757.5% by 2050 (not a guarantee).
Yes. The 2040 max is $136.78 and the 2050 max is $309.78, indicating potential to exceed $100 in those years.
Current price $20.58; market cap $907.43M; rank 2597.
Thirty-day range low $17.61, high $24.05.
Amphastar Pharmaceuticals, Inc. Community Discussion
0Share your Amphastar Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.